SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-006083
Filing Date
2022-02-09
Accepted
2022-02-09 12:20:09
Documents
1
Group Members
LAV BIOSCIENCES FUND III, L.P.LAV BIOSCIENCES FUND V SUB A, L.P.LAV OPPORTUNITY LTDYI SHI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea155135-13ga1lilly_nextcure.htm SC 13G/A 117809
  Complete submission text file 0001213900-22-006083.txt   119568
Mailing Address APPLEBY TRUST CAYMAN LTD., CLIFTON HOUSE 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108
Business Address APPLEBY TRUST CAYMAN LTD., CLIFTON HOUSE 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108 345-949-4900
Lilly Asia Ventures Fund III, L.P. (Filed by) CIK: 0001636031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91004 | Film No.: 22605329
SIC: 2834 Pharmaceutical Preparations